Scientific article

Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C

Published inJournal of hepatology, vol. 51, no. 4, p. 655-666
Publication date2009

BACKGROUND/AIMS: While several risk factors for the histological progression of chronic hepatitis C have been identified, the contribution of HCV genotypes to liver fibrosis evolution remains controversial. The aim of this study was to assess independent predictors for fibrosis progression. METHODS: We identified 1189 patients from the Swiss Hepatitis C Cohort database with at least one biopsy prior to antiviral treatment and assessable date of infection. Stage-constant fibrosis progression rate was assessed using the ratio of fibrosis Metavir score to duration of infection. Stage-specific fibrosis progression rates were obtained using a Markov model. Risk factors were assessed by univariate and multivariate regression models. RESULTS: Independent risk factors for accelerated stage-constant fibrosis progression (>0.083 fibrosis units/year) included male sex (OR=1.60, [95% CI 1.21-2.12], P<0.001), age at infection (OR=1.08, [1.06-1.09], P<0.001), histological activity (OR=2.03, [1.54-2.68], P<0.001) and genotype 3 (OR=1.89, [1.37-2.61], P<0.001). Slower progression rates were observed in patients infected by blood transfusion (P=0.02) and invasive procedures or needle stick (P=0.03), compared to those infected by intravenous drug use. Maximum likelihood estimates (95% CI) of stage-specific progression rates (fibrosis units/year) for genotype 3 versus the other genotypes were: F0-->F1: 0.126 (0.106-0.145) versus 0.091 (0.083-0.100), F1-->F2: 0.099 (0.080-0.117) versus 0.065 (0.058-0.073), F2-->F3: 0.077 (0.058-0.096) versus 0.068 (0.057-0.080) and F3-->F4: 0.171 (0.106-0.236) versus 0.112 (0.083-0.142, overall P<0.001). CONCLUSIONS: This study shows a significant association of genotype 3 with accelerated fibrosis using both stage-constant and stage-specific estimates of fibrosis progression rates. This observation may have important consequences for the management of patients infected with this genotype.

  • Adult
  • Cohort Studies
  • Disease Progression
  • Female
  • Fibrosis
  • Genotype
  • Hepacivirus/*genetics/*pathogenicity
  • Hepatitis C, Chronic/*pathology/*virology
  • Humans
  • Linear Models
  • Logistic Models
  • Male
  • Middle Aged
  • Risk Factors
  • Switzerland
  • Time Factors
  • Young Adult
Citation (ISO format)
BOCHUD, Pierre-Yves et al. Genotype 3 is associated with accelerated fibrosis progression in chronic hepatitis C. In: Journal of hepatology, 2009, vol. 51, n° 4, p. 655–666. doi: 10.1016/j.jhep.2009.05.016
Main files (1)
ISSN of the journal0168-8278

Technical informations

Creation04/23/2012 1:22:57 PM
First validation04/23/2012 1:22:57 PM
Update time03/14/2023 5:24:07 PM
Status update03/14/2023 5:24:07 PM
Last indexation02/12/2024 7:56:06 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack